Xeris Biopharma Holdings, Inc. (XERS) NASDAQ
$2.86 0.15 (5.54%)
Market Cap: $426.14M
As of 09/11/24 04:00 PM EDT. Market closed.
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ
$2.86
0.15 (5.54%)
Market Cap: $426.14M
As of 09/11/24 04:00 PM EDT. Market closed.
Add to Portfolio
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. John P. Shannon
Full Time Employees
377
CEO Compensation (Base)
$693,934
CEO Compensation (Total)
$2.14M
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. John P. Shannon
Full Time Employees
377
CEO Compensation (Base)
$693,934
CEO Compensation (Total)
$2.14M
Address
180 North LaSalle Street, IL, Chicago, 60601.
PRICE CHART FOR XERIS BIOPHARMA HOLDINGS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.69
Previous Close
$2.71
Days Range
$2.67 - $2.97
52 week range
$1.46 - $3.26
Volume
3,675,960
Avg. Volume (30 days)
1,405,612
Market Cap
$426.14M
Dividend Yield
-
P/E
(6.81)
Shares Outstanding
148,999,000
Open
$2.69
Previous Close
$2.71
Days Range
$2.67 - $2.97
52 week range
$1.46 - $3.26
Volume
3,675,960
Avg. Volume (30 days)
1,405,612
Market Cap
$426.14M
Dividend Yield
-
P/E
(6.81)
Shares Outstanding
148,999,000
FINANCIAL STATEMENTS FOR XERIS BIOPHARMA HOLDINGS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR XERIS BIOPHARMA HOLDINGS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Schmid John P. | Director | Aug 12, 2024 | Buy | $2.25 | 4,515 | 10,147 | 25,200 | Aug 13, 2024, 04:15 PM |
| Schmid John P. | Director | Aug 09, 2024 | Buy | $2.37 | 4,285 | 10,134 | 20,685 | Aug 12, 2024, 06:28 PM |
| Hecht Beth | See Remarks | Jan 29, 2022 | Option Exercise | $2.11 | 14,037 | 29,618 | 1,544,771 | Aug 09, 2024, 04:07 PM |
| Hecht Beth | See Remarks | Jan 29, 2024 | Option Exercise | $2.66 | 19,675 | 52,336 | 1,426,711 | Aug 09, 2024, 04:07 PM |
| Hecht Beth | See Remarks | Jan 03, 2024 | Option Exercise | $2.24 | 33,488 | 75,013 | 1,446,386 | Aug 09, 2024, 04:07 PM |
| Hecht Beth | See Remarks | Jan 31, 2023 | Option Exercise | $1.24 | 5,784 | 7,172 | 1,479,874 | Aug 09, 2024, 04:07 PM |
| Hecht Beth | See Remarks | Jan 29, 2023 | Option Exercise | $1.26 | 21,177 | 26,683 | 1,485,658 | Aug 09, 2024, 04:07 PM |
| Hecht Beth | See Remarks | Jan 03, 2023 | Option Exercise | $1.12 | 33,488 | 37,507 | 1,506,835 | Aug 09, 2024, 04:07 PM |
| Hecht Beth | See Remarks | Jan 31, 2022 | Option Exercise | $2.11 | 4,448 | 9,385 | 1,540,323 | Aug 09, 2024, 04:07 PM |
| Hecht Beth | See Remarks | Jan 31, 2024 | Option Exercise | $2.46 | 45,909 | 112,936 | 1,380,802 | Aug 09, 2024, 04:07 PM |
| JOHNSON KENNETH ERLAND | See Remarks | Jan 29, 2022 | Option Exercise | $2.11 | 7,497 | 15,819 | 440,443 | Aug 09, 2024, 04:07 PM |
| JOHNSON KENNETH ERLAND | See Remarks | Jan 29, 2024 | Option Exercise | $2.66 | 10,747 | 28,587 | 388,167 | Aug 09, 2024, 04:07 PM |
| JOHNSON KENNETH ERLAND | See Remarks | Jan 03, 2024 | Option Exercise | $2.24 | 12,400 | 27,776 | 398,914 | Aug 09, 2024, 04:07 PM |
| JOHNSON KENNETH ERLAND | See Remarks | Jan 31, 2023 | Option Exercise | $1.24 | 3,393 | 4,207 | 411,314 | Aug 09, 2024, 04:07 PM |
| JOHNSON KENNETH ERLAND | See Remarks | Jan 29, 2023 | Option Exercise | $1.26 | 11,029 | 13,897 | 414,707 | Aug 09, 2024, 04:07 PM |
| JOHNSON KENNETH ERLAND | See Remarks | Jan 03, 2023 | Option Exercise | $1.12 | 12,400 | 13,888 | 425,736 | Aug 09, 2024, 04:07 PM |
| JOHNSON KENNETH ERLAND | See Remarks | Jan 31, 2022 | Option Exercise | $2.11 | 2,307 | 4,868 | 438,136 | Aug 09, 2024, 04:07 PM |
| JOHNSON KENNETH ERLAND | See Remarks | Jan 31, 2024 | Option Exercise | $2.46 | 15,131 | 37,222 | 373,036 | Aug 09, 2024, 04:07 PM |
| Pieper Steven | See Remarks | Jan 31, 2023 | Option Exercise | $1.24 | 778 | 965 | 1,585,500 | Aug 09, 2024, 04:06 PM |
| Pieper Steven | See Remarks | Jan 29, 2023 | Option Exercise | $1.26 | 3,590 | 4,523 | 1,586,278 | Aug 09, 2024, 04:06 PM |
| Pieper Steven | See Remarks | Jul 28, 2024 | Option Exercise | $2.61 | 14,767 | 38,542 | 1,422,337 | Aug 09, 2024, 04:06 PM |
| Pieper Steven | See Remarks | Jan 03, 2023 | Option Exercise | $1.12 | 23,067 | 25,835 | 1,589,868 | Aug 09, 2024, 04:06 PM |
| Pieper Steven | See Remarks | Jan 31, 2024 | Option Exercise | $2.46 | 110,750 | 272,445 | 1,437,104 | Aug 09, 2024, 04:06 PM |
| Pieper Steven | See Remarks | Jul 28, 2022 | Option Exercise | $1.43 | 9,767 | 13,967 | 1,612,935 | Aug 09, 2024, 04:06 PM |
| Pieper Steven | See Remarks | Jan 29, 2024 | Option Exercise | $2.66 | 4,379 | 11,648 | 1,547,854 | Aug 09, 2024, 04:06 PM |
| Pieper Steven | See Remarks | Jan 31, 2022 | Option Exercise | $2.11 | 750 | 1,582 | 1,622,702 | Aug 09, 2024, 04:06 PM |
| Pieper Steven | See Remarks | Jan 03, 2024 | Option Exercise | $2.24 | 23,067 | 51,670 | 1,552,233 | Aug 09, 2024, 04:06 PM |
| Pieper Steven | See Remarks | Jan 29, 2022 | Option Exercise | $2.11 | 3,460 | 7,301 | 1,623,452 | Aug 09, 2024, 04:06 PM |
| Pieper Steven | See Remarks | Jul 28, 2023 | Option Exercise | $2.53 | 10,200 | 25,806 | 1,575,300 | Aug 09, 2024, 04:06 PM |
| Shannon John Patrick Jr | See Remarks | Jan 31, 2022 | Option Exercise | $2.11 | 7,497 | 15,819 | 2,396,423 | Aug 02, 2024, 05:22 PM |
| Shannon John Patrick Jr | See Remarks | Jan 31, 2024 | Option Exercise | $2.46 | 110,750 | 272,445 | 2,148,061 | Aug 02, 2024, 05:22 PM |
| Shannon John Patrick Jr | See Remarks | Jan 29, 2022 | Option Exercise | $2.11 | 15,692 | 33,110 | 2,403,920 | Aug 02, 2024, 05:22 PM |
| Shannon John Patrick Jr | See Remarks | Jan 29, 2024 | Option Exercise | $2.66 | 22,150 | 58,919 | 2,258,811 | Aug 02, 2024, 05:22 PM |
| Shannon John Patrick Jr | See Remarks | Jan 03, 2024 | Option Exercise | $2.24 | 40,834 | 91,468 | 2,280,961 | Aug 02, 2024, 05:22 PM |
| Shannon John Patrick Jr | See Remarks | Jan 31, 2023 | Option Exercise | $1.24 | 9,880 | 12,251 | 2,321,795 | Aug 02, 2024, 05:22 PM |
| Shannon John Patrick Jr | See Remarks | Jan 29, 2023 | Option Exercise | $1.26 | 23,414 | 29,502 | 2,331,675 | Aug 02, 2024, 05:22 PM |
| Shannon John Patrick Jr | See Remarks | Jan 03, 2023 | Option Exercise | $1.12 | 41,334 | 46,294 | 2,355,089 | Aug 02, 2024, 05:22 PM |
| Schmid John P. | Director | May 10, 2024 | Buy | $1.91 | 5,400 | 10,314 | 16,400 | May 10, 2024, 04:04 PM |
| JOHNSON JOHN | Director | Mar 18, 2024 | Option Exercise | $1.99 | 215,600 | 429,044 | 751,412 | Mar 18, 2024, 05:32 PM |
| Schmid John P. | Director | Mar 14, 2024 | Buy | $2.16 | 4,500 | 9,720 | 11,000 | Mar 14, 2024, 09:03 PM |
| SHERMAN JEFFREY W | Director | Nov 27, 2023 | Buy | $1.87 | 5,400 | 10,098 | 5,400 | Nov 29, 2023, 04:09 PM |
| HALKUFF DAWN | Director | Nov 20, 2023 | Buy | $1.84 | 5,410 | 9,954 | 5,410 | Nov 21, 2023, 04:20 PM |
| Pieper Steven | See Remarks | Nov 20, 2023 | Buy | $1.95 | 28,000 | 54,600 | 1,176,912 | Nov 21, 2023, 04:16 PM |
| Schmid John P. | Director | Nov 16, 2023 | Buy | $1.51 | 6,500 | 9,815 | 6,500 | Nov 17, 2023, 06:35 PM |
| Shannon John Patrick Jr | See Remarks | Nov 17, 2023 | Buy | $1.64 | 30,769 | 50,400 | 1,408,575 | Nov 17, 2023, 05:58 PM |
| PERSKY MARLA | Director | Nov 14, 2023 | Buy | $1.58 | 6,370 | 10,058 | 6,370 | Nov 15, 2023, 04:13 PM |
| Edick Paul R | See Remarks | Aug 09, 2023 | Buy | $2.38 | 10,000 | 23,794 | 2,288,064 | Aug 09, 2023, 06:57 PM |
| Edick Paul R | See Remarks | Dec 13, 2022 | Buy | $1.45 | 20,000 | 29,000 | 1,528,064 | Dec 14, 2022, 04:11 PM |
| BORMANN-KENNEDY BARBARA-JEAN ANNE | Director | Jun 08, 2022 | Option Exercise | $2.10 | 15,000 | 31,500 | 15,000 | Jun 09, 2022, 05:15 PM |
| Edick Paul R | See Remarks | May 12, 2022 | Buy | $1.40 | 100,000 | 140,380 | 1,508,064 | May 13, 2022, 04:19 PM |
| PRESTRELSKI STEVEN | Chief Scientific Officer | Feb 22, 2022 | Option Exercise | $0.69 | 11,228 | 7,747 | 581,008 | Feb 24, 2022, 04:28 PM |
| PRESTRELSKI STEVEN | Chief Scientific Officer | Feb 22, 2022 | Sale | $2.42 | 11,228 | 27,158 | 569,780 | Feb 24, 2022, 04:28 PM |
| Edick Paul R | See Remarks | Nov 15, 2021 | Buy | $2.28 | 20,000 | 45,664 | 33,430 | Nov 16, 2021, 04:25 PM |
| Shannon John Patrick Jr | See Remarks | Nov 11, 2021 | Buy | $2.09 | 40,000 | 83,500 | 303,829 | Nov 12, 2021, 05:12 PM |
| Shannon John Patrick Jr | See Remarks | Nov 12, 2021 | Buy | $2.10 | 60,000 | 126,000 | 363,829 | Nov 12, 2021, 05:12 PM |
| Edick Paul R | See Remarks | Nov 11, 2021 | Buy | $2.08 | 200,000 | 415,760 | 808,064 | Nov 12, 2021, 05:09 PM |
| Pieper Steven | See Remarks | Nov 10, 2021 | Buy | $2.00 | 25,000 | 49,918 | 183,108 | Nov 12, 2021, 05:06 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN XERIS BIOPHARMA HOLDINGS, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 10,332,078 | 0.00053% | 3.73% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 3,240,379 | 0.00064% | 6.4% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 1,351,640 | 0.00516% | 33.91% | Other |
| AQR CAPITAL MANAGEMENT LLC | 1,193,080 | 0.00411% | 4.56% | Other |
| D. E. SHAW & CO., INC. | 518,024 | 0.00109% | -26.73% | Other |
| ALPINE GLOBAL MANAGEMENT, LLC | 300,000 | 0.12% | -50% | Event Driven |
| TUDOR INVESTMENT CORP ET AL | 573,186 | 0.00661% | No change | Event Driven, Other |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | 170,937 | 0.03% | 12.91% | Value |
| ORBIMED ADVISORS LLC | 80,420 | 0.00357% | No change | Other |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 73,570 | 0.00283% | Exited | Other |
CHANGE IN SHARES OUTSTANDING FOR XERIS BIOPHARMA HOLDINGS, INC.
STOCK BUYBACKS FOR XERIS BIOPHARMA HOLDINGS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2024
5.57%
1Q
12/31/2023
7.40%
2Q
09/30/2023
7.45%
3Q
06/30/2023
8.01%
4Q
03/31/2023
8.17%
5Q
12/31/2022
9.09%
6Q
09/30/2022
9.12%
7Q
06/30/2022
9.46%
8Q
03/31/2022
9.86%
9Q
12/31/2021
87.71%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR XERIS BIOPHARMA HOLDINGS, INC.
LOADING...